Clinical cardio-oncology / created by Joerg Herrmann, MD, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Material type:
- text
- unmediated
- volume
- 9780323442275
- 0323442277
- RC681 HER
Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
Main Library Open Shelf | RC681 HER (Browse shelf(Opens below)) | 162122 | Available | BK150077 |
Includes bibliographical references and index.
Title page; Table of Contents; Copyright; Contributors; Preface; Introduction; Section 1: Oncology and Hematology Principles for the Cardiologist; Chapter 1. Principles of Cancer Treatment; Cancer presentation; Cancer staging; Cancer treatment; Radiation therapy; Supportive care for the patient with cancer; Myelotoxicity; Hypersensitivity reactions; Chapter 2. Introduction to Systemic Antineoplastic Treatments for Cardiologists; Introduction; Practical approaches to systemic anticancer treatments; Targeted cancer therapies; Antibody drug conjugates; Immune checkpoint therapies. The future of systemic anticancer treatmentChapter 3. Basics of Radiation Therapy; Introduction; Basic physics; Types of radiation; Sources of radiation; Radiation interactions in the body; Radiation treatment planning and delivery; Radiation treatment parameters; Relative biological effectiveness; Practical aspects of radiation therapy planning and delivery; Specific modalities; Specific disease sites; Summary; Chapter 4. Cardiac Tumors: Overview and Pathology; Overview; Nonneoplastic tumors; Pediatric and congenital tumors; Lesions of uncertain cause; Benign primary cardiac neoplasms. Malignant primary cardiac neoplasmsMetastatic cardiac neoplasms; Secondary effects of neoplasms on the heart; Chapter 5. Cardiac Tumors: Imaging; Introduction; Imaging modalities; Pseudotumors; Benign; Primary cardiac malignancies; Metastatic malignancies; Case study 1; Case study 2; Case study 3; Chapter 6. Cardiac Tumors: Treatment; Nonneoplastic tumors; Benign primary cardiac neoplasms; Primary malignant tumors; Secondary metastatic tumors; Right atrial extension of subdiaphragmatic tumors; Molecular- and biologic-based diagnosis and therapy for cardiac tumors; Important points; Case study. Supplementary dataChapter 7. Subtypes of Cancer Involving the Heart; Carcinoid; Cardiac amyloid; Pheochromocytoma; Diagnosis; Section 2: Cardiac Complications from Cancer Therapy; Chapter 8. Chemotherapy-Induced Cardiomyopathy; Introduction; Cardiomyopathies; Anthracyclines; Human epidermal growth factor receptor-2/epidermal growth factor receptor-2 targeted therapies; Anthracyclines and human epidermal growth factor receptor-2/epidermal growth factor receptor-2 targeted therapies; Approach to heart failure in the patients with cancer; Summary. Chapter 9. Vascular Toxicities of Cancer TherapiesPart 1: chemotherapeutics associated with vascular toxicity; Part 2: clinical presentations of chemotherapy-related vascular toxicities; Case study; History; Current medications; Current symptoms; Physical examination; Laboratory data; Electrocardiogram (if applicable. Please provide figure and brief description); Focused clinical questions and discussion points (provide 3 to 5 questions and discussions); Final diagnosis; Plan of action; Intervention; Outcome; Selected reference
There are no comments on this title.